Episode
FDA Approves First PCSK9 Pill for Cholesterol | US News
- Published
- Jul 17, 2026
- Duration seconds
- 120
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/c5d1e2e8803016a5
Actions
POST https://stenobird.com/v1/public/podcasts/us-news-today-2-min-news-the-daily-news-now-7023297/episodes/fda-approves-first-pcsk9-pill-for-cholesterol-us-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297/fda-approves-first-pcsk9-pill-for-cholesterol-us-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
FDA just approved Lipfendra, the first daily pill targeting PCSK9 to slash bad cholesterol—offering a cheaper, no-shot alternative to pricey injectables. At $315/month, it’s a game-changer for adults on max statins, slashing LDL by 56-59% in trials. Cardiologists are thrilled: this could make cholesterol control as routine as a daily statin, empowering primary care doctors and helping meet new heart attack/stroke prevention goals. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/c5d1e2e8803016a5